LGP — Little Green Pharma Share Price
Last trade - 00:00- AU$36.21m
- AU$36.22m
- AU$25.63m
- 59
- 69
- 52
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.5 | ||
| Price to Tang. Book | 0.52 | ||
| Price to Free Cashflow | 30.48 | ||
| Price to Sales | 1.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.6% | ||
| Return on Equity | -12.43% | ||
| Operating Margin | -30.92% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.2 | 7 | 10.53 | 19.86 | 25.63 | 29.8 | 35.5 | 152.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. Its principal activities include the cultivation of medicinal cannabis, procurement of raw materials and production of medicinal cannabis medicines; the supply of medicinal cannabis products into Australia and Europe; the supply of medicinal cannabis products for observational and clinical studies and research and development of new medicinal cannabis products, and the development of a psychedelics business including sponsoring a clinical trial into the treatment of refractory depression with psilocybin assisted therapy, construction of a psilocybin mushroom cultivation facility, and establishment of a psychedelic treatment clinic. It has two global production sites for the manufacture of its own-branded and white-label ranges medicinal cannabis products.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- October 27th, 2016
- Public Since
- February 20th, 2020
- No. of Shareholders
- 11,723
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 301,760,606
- Address
- Kings Park Road, West Perth,, PERTH, 6872
- Web
- https://www.littlegreenpharma.com/
- Phone
- +61 862800050
- Auditors
- BDO Audit (WA) PTY LTD
Latest News for LGP
Upcoming Events for LGP
Full Year 2025 Little Green Pharma Ltd Earnings Release
Similar to LGP
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Althea group
Australian Stock Exchange - SEATS
Anatara Lifesciences
Australian Stock Exchange - SEATS
Argent BioPharma
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:47 UTC, shares in Little Green Pharma are trading at AU$0.12. This share price information is delayed by 15 minutes.
Shares in Little Green Pharma last closed at AU$0.12 and the price had moved by -17.24% over the past 365 days. In terms of relative price strength the Little Green Pharma share price has underperformed the ASX All Ordinaries Index by -24.13% over the past year.
The overall consensus recommendation for Little Green Pharma is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreLittle Green Pharma does not currently pay a dividend.
Little Green Pharma does not currently pay a dividend.
Little Green Pharma does not currently pay a dividend.
To buy shares in Little Green Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.12, shares in Little Green Pharma had a market capitalisation of AU$36.21m.
Here are the trading details for Little Green Pharma:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: LGP
Based on an overall assessment of its quality, value and momentum Little Green Pharma is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Little Green Pharma is AU$0.17. That is 41.67% above the last closing price of AU$0.12.
Analysts covering Little Green Pharma currently have a consensus Earnings Per Share (EPS) forecast of -AU$1.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Little Green Pharma. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +18.17%.
As of the last closing price of AU$0.12, shares in Little Green Pharma were trading +5.76% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Little Green Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Little Green Pharma's management team is headed by:
- Michael Lynch-Bell - NEC
- Fleta Solomon - MDR
- Angus Caithness - EDR
- Alistair Warren - SEC
- Neale Fong - NID